Bystander effect of antibody–drug conjugates: fact or fiction? Federica GiuglianoChiara CortiGiuseppe Curigliano Breast Cancer (RA Leon Ferre, Section Editor) 19 March 2022 Pages: 809 - 817
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help? Thomas Yang SunAndrew HendifarSukhmani K. Padda Neuroendocrine Neoplasms (NS Reed, Section Editor) 19 March 2022 Pages: 819 - 824
Treatment of Metastatic Melanoma in the Elderly Rino S. SeedorMarlana Orloff Geriatric Oncology (L Balducci, Section Editor) 22 March 2022 Pages: 825 - 833
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections Francisco Moreno-SanchezBrenda Gomez-Gomez Leukemia (A Aguayo, Section Editor) 22 March 2022 Pages: 835 - 842
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group Angela TossPaola QuarelloAndrea Ferrari Pediatric Oncology (KL Davis, Section Editor) Open access 23 March 2022 Pages: 843 - 860
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients Alexander R. MoschenYossi SammyAgnieszka M. Marczewska Palliative Medicine (A Jatoi, Section Editor) 24 March 2022 Pages: 861 - 874
The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies Carlos E. Guerra-LondonoCarlos G. TarazonaRupen Shah Anesthesiology and Critical Care (JP Cata, Section Editor) 24 March 2022 Pages: 875 - 887
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers Juliet E. WolfordErin FerrigniThomas J. Herzog Gynecologic Cancers (J Brown and RW Naumann, Section Editors) 26 March 2022 Pages: 889 - 904
Anti-PD-1: When to Stop Treatment Y. JansenA. A. M. van der VeldtB. Neyns Melanoma (DB Johnson, Section Editor) 26 March 2022 Pages: 905 - 915
The Treatment Landscape of Advanced Hepatocellular Carcinoma Kit Man WongGentry G. KingWilliam P. Harris Gastrointestinal Cancers (J Meyer, Section Editor) 26 March 2022 Pages: 917 - 927
Viral and Clinical Oncology of Head and Neck Cancers Peter GoonMatthias SchürmannHolger Sudhoff Head and Neck Cancers (EY Hanna, Section Editor) Open access 26 March 2022 Pages: 929 - 942
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge Laura B. VaterBénédicte LefebvreSuparna C. Clasen Cardio-oncology (JN Upshaw, Section Editor) 26 March 2022 Pages: 943 - 950
Current Clinical Trial Landscape of OX40 Agonists Rashi YadavWilliam L. Redmond Immuno-oncology (RM Bukowski and JH Finke, Section Editors) 29 March 2022 Pages: 951 - 960